atenolol has been researched along with Colorectal Cancer in 4 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with a colorectal cancer- specific death (data from the Office of National Statistics death registration system) were matched to five controls." | 1.39 | β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort. ( Cardwell, CR; Hicks, BM; Hughes, CM; Murray, LJ; Powe, DG, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, Q | 1 |
Wang, F | 1 |
Yang, R | 1 |
Zheng, X | 1 |
Gao, H | 1 |
Zhang, P | 1 |
Hicks, BM | 1 |
Murray, LJ | 1 |
Powe, DG | 1 |
Hughes, CM | 1 |
Cardwell, CR | 1 |
Coelho, M | 1 |
Moz, M | 1 |
Correia, G | 1 |
Teixeira, A | 1 |
Medeiros, R | 1 |
Ribeiro, L | 1 |
Chin, CC | 1 |
Li, JM | 1 |
Lee, KF | 1 |
Huang, YC | 1 |
Wang, KC | 1 |
Lai, HC | 1 |
Cheng, CC | 1 |
Kuo, YH | 1 |
Shi, CS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Perioperative β-adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.[NCT00888797] | Phase 3 | 400 participants (Anticipated) | Interventional | 2010-01-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for atenolol and Colorectal Cancer
Article | Year |
---|---|
Effect of chronic restraint stress on human colorectal carcinoma growth in mice.
Topics: Adrenergic Antagonists; Animals; Atenolol; Cell Proliferation; Colorectal Neoplasms; Epinephrine; Ge | 2013 |
β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Case | 2013 |
Antiproliferative effects of β-blockers on human colorectal cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedi | 2015 |
Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Apoptosis; | 2016 |